Home/Pipeline/abnobaVISCUM (Host-tree specific extracts)

abnobaVISCUM (Host-tree specific extracts)

Supportive therapy in oncology (improving quality of life, reducing side effects of chemo/radiotherapy)

Approved/CommercialActive

Key Facts

Indication
Supportive therapy in oncology (improving quality of life, reducing side effects of chemo/radiotherapy)
Phase
Approved/Commercial
Status
Active
Company

About Abnoba

Abnoba GmbH is a long-established, private German biopharmaceutical company with a singular focus on mistletoe-based supportive cancer care. The company leverages over 50 years of experience in producing standardized mistletoe extracts (abnobaVISCUM) aimed at improving patients' immune response and quality of life during and after surgery, chemotherapy, and radiotherapy. It operates as a commercial-stage entity, generating revenue from its approved products, which are primarily marketed in German-speaking and select European countries. Abnoba's strategy is built on deep expertise in phytopharmaceuticals, ongoing clinical research, and educating healthcare professionals and patients on integrative oncology.

View full company profile

Therapeutic Areas